Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Cancer Metastasis Reviews|July 5, 2017
Platelet-activating factor podoplanin: from discovery to drug developmentAi Takemoto, Kenichi Miyata, Naoya FujitaThe Journal of Biological Chemistry|November 11, 2003
Cell cycle-dependent phosphorylation, nuclear localization, and activation of human condensinAi Takemoto, Keiji Kimura, Shigeyuki Yokoyama, et al.Chemistry & Biology|February 27, 2013
A chemical biology strategy to analyze rheostat-like protein kinase-dependent regulationShigehiro A Kawashima, Ai Takemoto, Paul Nurse, et al.Oncotarget|October 4, 2018
A safety study of newly generated anti-podoplanin-neutralizing antibody in cynomolgus monkey (<i>Macaca fascicularis</i>)Takao Ukaji, Ai Takemoto, Ryohei Katayama, et al.Scientific Reports|June 24, 2017
Podoplanin enhances lung cancer cell growth in vivo by inducing platelet aggregationKenichi Miyata, Ai Takemoto, Sakae Okumura, et al.The EMBO Journal|October 27, 2006
Negative regulation of condensin I by CK2-mediated phosphorylationAi Takemoto, Keiji Kimura, Junn Yanagisawa, et al.Chemistry & Biology|July 31, 2012
Analyzing fission yeast multidrug resistance mechanisms to develop a genetically tractable model system for chemical biologyShigehiro A Kawashima, Ai Takemoto, Paul Nurse, et al.Cancer Science|July 1, 2014
Platelets promote osteosarcoma cell growth through activation of the platelet-derived growth factor receptor-Akt signaling axisSatoshi Takagi, Ai Takemoto, Miho Takami, et al.Cancer Science|March 18, 2021
Novel knock-in mouse model for the evaluation of the therapeutic efficacy and toxicity of human podoplanin-targeting agentsTakao Ukaji, Ai Takemoto, Harumi Shibata, et al.Oncotarget|December 20, 2015
Targeting a novel domain in podoplanin for inhibiting platelet-mediated tumor metastasisTakaya Sekiguchi, Ai Takemoto, Satoshi Takagi, et al.Pageof 3